Jack Nathan Medical Corp.
JNHMF
$0.0036
-$0.0001-2.70%
OTC PK
| 01/31/2025 | 10/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -243.92% | -2.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -243.92% | -2.36% | |||
| Cost of Revenue | -304.68% | -16.01% | |||
| Gross Profit | -230.27% | 1.34% | |||
| SG&A Expenses | -233.04% | -5.52% | |||
| Depreciation & Amortization | -324.07% | -3.43% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -248.08% | -7.13% | |||
| Operating Income | 265.27% | 22.73% | |||
| Income Before Tax | 302.86% | 22.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 307.82% | 22.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 842.60% | 22.43% | |||
| EBIT | 265.27% | 22.73% | |||
| EBITDA | 311.89% | 26.70% | |||
| EPS Basic | 842.38% | 22.56% | |||
| Normalized Basic EPS | 303.19% | 22.95% | |||
| EPS Diluted | 835.76% | 22.56% | |||
| Normalized Diluted EPS | 323.26% | 29.51% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -9.02% | 10.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||